Skip to main content
Journal of the National Medical Association logoLink to Journal of the National Medical Association
letter
. 1980 Oct;72(10):965–972.

Chronic Airways Obstruction in Pulmonary Sarcoidosis: Its Poor Response to Bronchodilators

Roscoe C Young Jr, Gul K Sahetya, Sheik N Hassan, William B Cobb, Bharath Kumar, Harold T Facen
PMCID: PMC2552536  PMID: 7420439

Abstract

Emphysema, chronic bronchitis, asthma, and cystic fibrosis are often cited as examples of chronic airways obstruction, while sarcoidosis is typically restrictive. Approximately 15 percent of sarcoidosis patients, however, have airways obstruction clinically characterized by wheezing with granulomatous involvement of airways. Since the majority have Stage IV disease by chest radiograph, their lungs usually have honey-combining with pulmonary fibrosis, adhesions, cavities, and mediastinal distortion.

Patients had a mixed ventilatory defect, but obstruction of large airways was present as shown by decreased specific airways conductances. Small airways obstruction was also present as shown by low instantaneous flows at the terminal portion of the maximum expiratory flow-volume curve and diminished helium response of this curve. The closing volume, however, was not very sensitive. Radioactive xenon washout from ventilation lung scans and N2 washout from the lungs were prolonged in patients with worse disease.

The authors conclude that the obstructive type of physiologic pattern is more frequent than recognized in sarcoidosis, which like that of cystic fibrosis has some restrictive element and is characterized by poor reversibility to bronchodilators. A trial period of beclomethasone dipropionate aerosol was not helpful in two patients. Relief of this distressing airways obstruction continues to pose a challenging problem in management.

Full text

PDF
968

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Benatar S. R., Clark T. J. Pulmonary function in a case of endobronchial sarcoidosis. Am Rev Respir Dis. 1974 Oct;110(4):490–496. doi: 10.1164/arrd.1974.110.4.490. [DOI] [PubMed] [Google Scholar]
  2. COATES E. O., COMROE J. H., Jr Pulmonary function studies in sarcoidosis. J Clin Invest. 1951 Aug;30(8):848–852. doi: 10.1172/JCI102499. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. DeRemee R. A., Andersen H. A. Sarcoidosis: a correlation of dyspnea with roentgenographic stage and pulmonary function changes. Mayo Clin Proc. 1974 Oct;49(10):742–745. [PubMed] [Google Scholar]
  4. Dosman J., Bode F., Urbanetti J., Martin R., Macklem P. T. The Use of a Helium-Oxygen Mixture during Maximum Expiratory Flow to Demonstrate Obstruction in Small Airways in Smokers. J Clin Invest. 1975 May;55(5):1090–1099. doi: 10.1172/JCI108010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. HARDEN K. A., BARTHAKUR A., CARR C. Sarcoidosis; a functional classification. Med Ann Dist Columbia. 1959 Mar;28(3):129–133. [PubMed] [Google Scholar]
  6. Kaneko K., Sharma O. P. Airway obstruction in pulmonary sarcoidosis. Bull Eur Physiopathol Respir. 1977 Mar-Apr;13(2):231–240. [PubMed] [Google Scholar]
  7. Levinson R. S., Metzger L. F., Stanley N. N., Kelsen S. G., Altose M. D., Cherniack N. S., Brody J. S. Airway function in sarcoidosis. Am J Med. 1977 Jan;62(1):51–59. doi: 10.1016/0002-9343(77)90349-7. [DOI] [PubMed] [Google Scholar]
  8. MCCLEMENT J. H., RENZETTI A. D., HIMMELSTEIN A., COURNAND A. Cardiopulmonary function in the pulmonary form of Boeck's sarcoid and its modification by cortisone therapy. Am Rev Tuberc. 1953 Feb;67(2):154–172. doi: 10.1164/art.1953.67.2.154. [DOI] [PubMed] [Google Scholar]
  9. McCarthy D. S., Spencer R., Greene R., Milic-Emili J. Measurement of "closing volume" as a simple and sensitive test for early detection of small airway disease. Am J Med. 1972 Jun;52(6):747–753. doi: 10.1016/0002-9343(72)90080-0. [DOI] [PubMed] [Google Scholar]
  10. Miller A., Teirstein A. S., Jackler I., Chuang M., Siltzbach L. E. Airway function in chronic pulmonary sarcoidosis with fibrosis. Am Rev Respir Dis. 1974 Feb;109(2):179–189. doi: 10.1164/arrd.1974.109.2.179. [DOI] [PubMed] [Google Scholar]
  11. Renzi G., Dutton R. E. Pulmonary function in diffuse sarcoidosis. Respiration. 1974;31(2):124–136. doi: 10.1159/000193104. [DOI] [PubMed] [Google Scholar]
  12. STONE D. J., SCHWARTZ A., FELTMAN J. A., LOVELOCK F. J. Pulmonary function in sarcoidosis; results with cortisone therapy. Am J Med. 1953 Oct;15(4):468–476. doi: 10.1016/0002-9343(53)90137-5. [DOI] [PubMed] [Google Scholar]
  13. Young R. C., Jr, Headings V. E., Bose S., Harden K. A., Crockett E. D., Jr, Hackney R. L., Jr Alpha 1 antitrypsin levels in sarcoidosis: relationship to disease activity. Chest. 1973 Jul;64(1):39–45. doi: 10.1378/chest.64.1.39. [DOI] [PubMed] [Google Scholar]

Articles from Journal of the National Medical Association are provided here courtesy of National Medical Association

RESOURCES